Therapy-Related Myeloid Neoplasm Has a Higher Subclonal Mutation Burden Than De Novo AML

被引:0
|
作者
Zheng, Gang [1 ]
Pallavajjalla, Aparna [1 ]
Haley, Lisa [1 ]
Lin, Ming-Tseh [1 ]
Eshleman, James R. [1 ]
Gondek, Lukasz [1 ]
Borowitz, Michael [1 ]
Duffield, Amy [1 ]
Burns, Kathleen H. [1 ]
Gocke, Christopher D. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1555
引用
收藏
页码:388A / 388A
页数:1
相关论文
共 50 条
  • [1] Therapy-Related Myeloid Neoplasm Has a Higher Subclonal Mutation Burden Than De Novo AML
    Zheng, Gang
    Pallavajjalla, Aparna
    Haley, Lisa
    Lin, Ming-Tseh
    Eshleman, James R.
    Gondek, Lukasz
    Borowitz, Michael
    Duffield, Amy
    Burns, Kathleen H.
    Gocke, Christopher D.
    LABORATORY INVESTIGATION, 2017, 97 : 388A - 388A
  • [2] Prevalence of Subclonal Mutations in Therapy-related Myeloid Neoplasms and de novo AMLs
    Zheng, G.
    Pallavajjalla, A.
    Haley, L.
    Lin, M.
    Eshleman, J.
    Gocke, C. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 960 - 960
  • [3] Who Has Therapy-Related AML?
    Gale, Robert Peter
    Bennett, John M.
    Hoffman, F. Owen
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
  • [4] Outcome of Patients (pts) with Therapy-Related De Novo Acute Myeloid Leukemia (t-de novo AML): Single Institution Experience
    Sasaki, Koji
    Jabbour, Elias
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Pierce, Sherry R.
    Pemmaraju, Naveen
    O'Brien, Susan
    Ravandi, Farhad
    BLOOD, 2014, 124 (21)
  • [5] THERAPY-RELATED ACUTE MYELOID LEUKEMIA (T-AML) VERSUS AML WITH MYELODYSPLASIA-RELATED CHANGES AND DE NOVO AML: CLINICOBIOLOGICAL DIFFERENCES AND OUTCOME
    Lalayanni, C.
    Antoniou, A.
    Baliakas, P.
    Iskas, M.
    Georgiadou, E.
    Marvaki, A.
    Syrigou, A.
    Athanasiadou, A.
    Anagnostopoulos, A.
    HAEMATOLOGICA, 2012, 97 : 503 - 503
  • [6] AML and MDS Following Radiation Therapy Are Similar to De Novo Disease and Differ from Other Therapy-Related Myeloid Neoplasms
    Nardi, V.
    Kluk, M.
    Attar, E.
    Winkfield, K.
    Hasserjian, R. P.
    LABORATORY INVESTIGATION, 2011, 91 : 309A - +
  • [7] Isolated Orbital Myeloid Sarcoma as a Therapy-related Myeloid Neoplasm
    Ishiguro, Kazuya
    Takahashi, Tohru
    INTERNAL MEDICINE, 2019, 58 (07) : 1045 - 1046
  • [8] Estimating Therapy-Related Myeloid Neoplasm Risks in the US
    Radivoyevitch, Tomas
    Sachs, Rainer K.
    Gale, Robert Peter
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    Kalaycio, Matt
    Mukherjee, Sudipto
    BLOOD, 2014, 124 (21)
  • [9] Impact of Therapy-Related De Novo Acute Myeloid Leukemia on Response and Survival
    Sasaki, Koji
    Jabbour, Elias
    Kantarjian, Hagop
    Cortes, Jorge
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Pierce, Sherry
    Pemmaraju, Naveen
    O'Brien, Susan
    Ravandi, Farhad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S181 - S182
  • [10] Treatment Outcome for Therapy-related Myeloid Neoplasm in Children
    Cheng, F. W. T.
    Lam, G. K. S.
    Chow, T. T. W.
    Shing, M. M. K.
    Lee, V
    Li, C. K.
    HONG KONG JOURNAL OF PAEDIATRICS, 2019, 24 (04) : 179 - 183